Buscar
Mostrando ítems 31-40 de 1001
Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: A double-blind controlled pilot study
(2006-03-01)
Objective: This study evaluated the augmentation of venlafaxine with hormone therapy in the treatment of postmenopausal depression. The hormones evaluated were estrogen (0.625 mg) in combination with medroxyprogesterone ...
Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: A double-blind controlled pilot study
(2006-03-01)
Objective: This study evaluated the augmentation of venlafaxine with hormone therapy in the treatment of postmenopausal depression. The hormones evaluated were estrogen (0.625 mg) in combination with medroxyprogesterone ...
Hormonal therapy in the senescence: Prostatic microenvironment structure and adhesion molecules
(Pergamon-Elsevier B.V. Ltd, 2011-08-01)
Hormonal replacement has been utilized to minimize the harmful effects of hormonal imbalance in elderly men. The development and progression of prostatic diseases and their relation to hormone therapy is still unclear. ...
Hormonal therapy in the senescence: Prostatic microenvironment structure and adhesion molecules
(Pergamon-Elsevier B.V. Ltd, 2011-08-01)
Hormonal replacement has been utilized to minimize the harmful effects of hormonal imbalance in elderly men. The development and progression of prostatic diseases and their relation to hormone therapy is still unclear. ...
Randomized trial of early bubble continuous positive airway pressure for very low birth weight infants
(Elsevier, 2012)
Objective: To determine whether very low birth weight infants (VLBWIs), initially supported with continuous positive airway pressure (CPAP) and then selectively treated with the INSURE (intubation, surfactant, and extubation ...
Treatment of fibrocystic disease of the breast with gestrinone, a new trienic synthetic steroid with anti-estrogen, anti-progesterone properties
(International Journal of Gynecology & Obstetrics, 1984)
Coutinho EM (Maternidade Climerio de
Oliveira, Department of Maternal Health,
Federal University of Bahia, School of Medicine,
Salvador, Bahia, Brazil), Azadian-
Boulanger G (Roussel-Uclaf, Paris, France).
Treatment of ...
Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
(BENTHAM SCIENCE PUBL LTD, 2010)
Ruthenium compounds have been actively studied as metallodrugs for cancer therapy. Representatives of ruthenium-based antitumor drugs are the classes of ruthenium(III)-chlorido-(N-ligand)complexes, including the drugs ...